{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:20:29Z","timestamp":1788261629557,"version":"build-2803163510"},"reference-count":45,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Background: Acute upper gastrointestinal bleeding (AUGIB) is a critical clinical condition with high morbidity and mortality, necessitating effective therapeutic interventions. Objectives: This study retrospectively investigated the efficacy of tranexamic acid combined with octreotide (OCT) in patients with high risk of AUGIB. Methods: A total of 183 patients with UGIB were initially enrolled, and 170 eligible patients were finally included and divided into an OCT group (n=83) and a TXA + OCT group (n=87). The main indicators compared were: drug onset time, hemostasis time, upper gastrointestinal bleeding volume, blood routine, coagulation function and clinical effective rate; secondary indicators: clinical efficacy, visual analogue scale (VAS) and adverse reactions. Results: After treatment, the onset time, hemostasis time, bleeding volume, coagulation function indexes (PT, TT, APTT and Fib) and VAS in TXA group and OCT group were significantly lower than those in OCT group. The clinical effective rate and hemoglobin, red blood cell and platelet count in TXA group and OCT group were significantly higher than those in OCT group (P&lt;0.05). There were no significant differences in the average blood transfusion volume, hospitalization time, rebleeding rate within 3 days, surgical intervention needs and mortality between the two groups (P&gt;0.05), but the combined group had a slight advantage. In addition, combination therapy did not increase the incidence of adverse reactions. Conclusion: These findings provide valuable clinical evidence supporting the use of tranexamic acid in combination with octreotide for AUGIB.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.6.172.1","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:56:55Z","timestamp":1776934615000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy Of Tranexamic Acid Combined With Octreotide In Acute Upper Gastrointestinal Bleeding: A Retrospective Clinical Controlled Study Of High-Risk Patients"],"prefix":"10.36721","author":[{"given":"Yuqian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Abraham L, Tharian S and Um A (2025). Comparison of the quick sequential organ failure assessment (qSOFA) score with the glasgow-blatchford score (GBS) and rockall score (RS) in predicting the need for intensive care among acute upper gastrointestinal bleeding patients. Cureus, 17(3): e80613.","DOI":"10.7759\/cureus.80613"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Abrishami M, Peymani P, Zare M and Lankarani KB (2020). The effect of octreotide in acute nonvariceal upper gastrointestinal bleeding: A randomized, double-blind, placebo-controlled trial. J Res Pharm Pract, 9(2): 94-100.","DOI":"10.4103\/jrpp.JRPP_19_57"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Akhtar MZ, Huq MU, Adwani R, Usman, A., Ijaz, S., and Seher, I. (2023). Utilizing endoscopy for the diagnosis of acute upper gastrointestinal bleeding. Cureus, 15(6): e40994.","DOI":"10.7759\/cureus.40994"},{"key":"ref3","unstructured":"Antunes C, Tian C and Copelin IE (2025). Upper gastrointestinal bleeding. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F and Bardou M (2019). Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the international consensus group. Ann Intern Med, 171(11): 805-822.","DOI":"10.7326\/M19-1795"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Batagello CA, Vicentini FC, Monga M, Miller AW, Marchini GS, Torricelli FCM and Mazzucchi E (2022). Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: A randomised, double-blinded, placebo-controlled trial. BJU Int, 129(1): 35-47.","DOI":"10.1111\/bju.15378"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Benedeto-Stojanov D, Bjelakovic M, Stojanov D and Aleksovski B (2022). Prediction of in-hospital mortality after acute upper gastrointestinal bleeding: Cross-validation of several risk scoring systems. J Int Med Res, 50(3): 3000605221086442.","DOI":"10.1177\/03000605221086442"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Colomina MJ, Contreras L, Guilabert P, Koo M, EMN and Sabate A (2022). Clinical use of tranexamic acid: evidences and controversies. Braz J Anesthesiol, 72(6): 795-812.","DOI":"10.1016\/j.bjane.2021.08.022"},{"key":"ref8","unstructured":"Correa TL, Antunes VLJ, Bulhoes E, Bolner G, Martins OC, de Mesquita CF and Baraldo S (2024). Somatostatin analogs in the treatment of gastrointestinal angiodysplasia bleeding: A systematic review. Gastroenterol Hepatol Bed Bench, 17(4): 349-356."},{"key":"ref9","unstructured":"Debnath D and Cheriyath P (2025). Octreotide. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Faraoni D and Fenger-Eriksen C (2024). Dosing of tranexamic acid in trauma. Curr Opin Anaesthesiol, 37(2): 125-130.","DOI":"10.1097\/ACO.0000000000001357"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Franchini M, Focosi D and Mannucci PM (2024). Tranexamic acid: An evergreen hemostatic agent. Semin Thromb Hemost, 50(5): 733-738.","DOI":"10.1055\/s-0044-1779632"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Franco MC, Jang S, Martins BDC, Stevens T, Jairath V, Lopez R, Maluf-Filho F (2022). Risk stratification in cancer patients with acute upper gastrointestinal bleeding: Comparison of glasgow-blatchford, rockall and AIMS65 and development of a new scoring system. Clin Endosc, 55(2): 240-247.","DOI":"10.5946\/ce.2021.115"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Grocott MPW, Murphy M, Roberts I, Sayers R and Toh CH (2022). Tranexamic acid for safer surgery: The time is now. Br J Anaesth, 129(4): 459-461.","DOI":"10.1016\/j.bja.2022.06.024"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gupta N and Gupta A (2022). Acute upper gastrointestinal bleeding: A stitch on time saves nine. World J Gastrointest Endosc, 14(5): 351-353.","DOI":"10.4253\/wjge.v14.i5.351"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Hao S, Li B, Luo S, Dong S, Liu S, Li H and Cao X (2024). The effect of preoperative use of anticoagulants on the hemostatic effect of intravenous application of tranexamic acid in PLIF: A case control study. Sci Rep, 14(1): 10997.","DOI":"10.1038\/s41598-024-60440-9"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Hao S, Li H, Liu S, Meng S, Zhang X, Wang L and Dong S (2023). The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: A randomized clinical trial. Sci Rep, 13(1): 4714.","DOI":"10.1038\/s41598-022-27307-3"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Horibe M, Ogura Y, Matsuzaki J, Kaneko T, Yokota T, Okawa O and Kanai T (2018). Absence of high-risk stigmata predicts good prognosis even in severely anemic patients with suspected acute upper gastrointestinal bleeding. United European Gastroenterol J, 6(5): 684-690.","DOI":"10.1177\/2050640618764161"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Houghton KD, Umar B and Schairer J (2019). Successful treatment of hereditary hemorrhagic telangiectasia with octreotide. ACG Case Rep J, 6(6): e00088.","DOI":"10.14309\/crj.0000000000000088"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Huang AS, Wu J, Amin A, Fu XQ and Yu ZL (2024). Traditional Chinese medicine in treating upper digestive tract cancers. Mol Cancer, 23(1): 250.","DOI":"10.1186\/s12943-024-02149-x"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ibrahim A, Allam J and Rockey DC (2025). Octreotide therapy in patients with a left ventricular assist device and bleeding gastrointestinal angiodysplasias. Am J Med Sci, 370(1): 41-46.","DOI":"10.1016\/j.amjms.2025.03.008"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Khedr A, Mahmoud EE, Attallah N, Mir M, Boike S, Rauf I and Khan SA (2022). Role of octreotide in small bowel bleeding. World J Clin Cases, 10(26): 9192-9206.","DOI":"10.12998\/wjcc.v10.i26.9192"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lee AY and Cho JY (2024). Advancements in hemostatic strategies for managing upper gastrointestinal bleeding: A comprehensive review. World J Gastroenterol, 30(15): 2087-2090.","DOI":"10.3748\/wjg.v30.i15.2087"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Lee PL, Yang KS, Tsai HW, Hou SK, Kang YN and Chang CC (2021). Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials. Am J Emerg Med, 45: 269-279.","DOI":"10.1016\/j.ajem.2020.08.062"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Lei T, Bingtao W, Zhaoqing G, Zhongqiang C and Xin L (2022). The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: A prospective randomized controlled trial. BMC Musculoskelet Disord, 23(1): 410.","DOI":"10.1186\/s12891-022-05361-2"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Long B and Gottlieb M (2024). Emergency medicine updates: Upper gastrointestinal bleeding. Am J Emerg Med, 81, 116-123.","DOI":"10.1016\/j.ajem.2024.04.052"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Mas E, Borrelli O, Broekaert I, de-Carpi JM, Dolinsek J, Miele E and Benninga MA (2022). Drugs in focus: Octreotide use in children with gastrointestinal disorders. J Pediatr Gastroenterol Nutr, 74(1): 1-6.","DOI":"10.1097\/MPG.0000000000003294"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Morales Santias M, Mas Martinez J, Sanz-Reig J, Martinez Gimenez E, Verdu Roman C and Bustamante Suarez de Puga D (2020). Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: A prospective randomized study. Eur J Orthop Surg Traumatol, 30(6): 1003-1008.","DOI":"10.1007\/s00590-020-02656-9"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Omoronyia EE, Ekuma MI, Eyong E, Abeshi SE and Akpan UB (2025). Effect of prophylactic tranexamic acid on peripartum changes in haemoglobin concentration after vaginal delivery. Sultan Qaboos Univ Med J, 25(1): 363-369.","DOI":"10.18295\/squmj.10.2024.055"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Orpen-Palmer J and Stanley AJ (2023). A review of risk scores within upper gastrointestinal bleeding. J Clin Med, 12(11): 3678.","DOI":"10.3390\/jcm12113678"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO and Okafor CG (2024). Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial. Womens Health (Lond), 20: 17455057231225311.","DOI":"10.1177\/17455057231225311"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Papantoniou K, Aggeletopoulou I, Pastras P and Triantos C (2025). The role of somatostatin in the gastrointestinal tract. Biology (Basel), 14(5): 558.","DOI":"10.3390\/biology14050558"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Park LJ, Marcucci M, Ofori SN, Borges FK, Nenshi R, Kanstrup CTB and Devereaux PJ (2025). Safety and efficacy of tranexamic acid in general surgery. JAMA Surg, 160(3): 267-274.","DOI":"10.1001\/jamasurg.2024.6048"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Peng YX and Chang WP (2024). Risk factors for peptic ulcer bleeding one year after the initial episode. Gut Pathog, 16(1): 71.","DOI":"10.1186\/s13099-024-00669-x"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Prudovsky I, Kacer D, Zucco VV, Palmeri M, Falank C, Kramer R and Rappold J (2022). Tranexamic acid: Beyond antifibrinolysis. Transfusion, 62(Suppl 1): S301-s312.","DOI":"10.1111\/trf.16976"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Robinson CL, Phung A, Dominguez M, Remotti E, Ricciardelli R, Momah DU and Gill J (2024). Pain scales: What are they and what do they mean. Curr Pain Headache Rep, 28(1): 11-25.","DOI":"10.1007\/s11916-023-01195-2"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Stanley AJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R and Laursen SB (2017). Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: International multicentre prospective study. BMJ, 356: i6432.","DOI":"10.1136\/bmj.i6432"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"t Hart JWH, Noordman BJ, Wijnand JMA, Biter LU, Verbrugge SJC, Birnie E and Apers JA (2023). Peroperative administration of tranexamic acid in sleeve gastrectomy to reduce hemorrhage: A double-blind randomized controlled trial. Surg Endosc, 37(10): 7455-7463.","DOI":"10.1007\/s00464-023-10232-5"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wang X, Liu Y, Zhao J and Zhang J (2019). Clinical efficacy of octreotide acetate combined with thrombin in the treatment of liver cirrhosis complicated with gastrointestinal hemorrhage. Exp Ther Med, 17(5): 3417-3422.","DOI":"10.3892\/etm.2019.7345"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wasserman RD, Abel W, Monkemuller K, Yeaton P, Kesar V and Kesar V (2024). Non-variceal upper gastrointestinal bleeding and its endoscopic management. Turk J Gastroenterol, 35(8): 599-608.","DOI":"10.5152\/tjg.2024.23507"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Yan L, Yang H, Jiang H, Yu M, Tan J, Su T and Xu G (2021). Impact of the tranexamic acid on bleeding amount of surgical patient with degenerative spinal disease: A randomized blinded study. Front Surg, 8: 655692.","DOI":"10.3389\/fsurg.2021.655692"},{"key":"ref41","unstructured":"Yang, L. (2022). Current interventional management of acute upper gastrointestinal bleeding. Sichuan Da Xue Xue Bao Yi Xue Ban, 53(3): 361-366."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Yang M, Zhang SQ and Huang J (2025). Octreotide combined with pantoprazole in the treatment of elderly patients with peptic ulcer complicated by upper gastrointestinal bleeding. Front Pharmacol, 16: 1623530.","DOI":"10.3389\/fphar.2025.1623530"},{"key":"ref43","unstructured":"Zhou D, Zhao P and Yang H (2024). The clinical effect of octreotide combined with upper endoscopy in the treatment of peptic ulcer complicated with upper gastrointestinal hemorrhage. Altern Ther Health Med, 30(11): 34-39."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Zhu Y, Ren Y, Li C, Si Z and Chi N (2023). Comparison of clinical effect of octreotide and pituitrin in treatment of upper gastrointestinal hemorrhage in cirrhosis. Indian J Pharmacol, 55(1): 21-26.","DOI":"10.4103\/ijp.ijp_653_21"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:08:39Z","timestamp":1788260919000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":45,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.6.172.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}